UK markets close in 1 hour 2 minutes

Lonza Group Ltd (LZAGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
573.75+10.75 (+1.91%)
As of 09:43AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close563.00
Open573.75
Bid0.00 x 0
Ask0.00 x 0
Day's range573.75 - 573.75
52-week range498.54 - 852.25
Volume15
Avg. volume225
Market cap42.62B
Beta (5Y monthly)0.59
PE ratio (TTM)74.42
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield3.01 (0.55%)
Ex-dividend date09 May 2022
1y target estN/A
  • EQS Group

    Maria Soler Nunez appointed as Head, Group Operations

    Lonza Group AG / Key word(s): PersonnelMaria Soler Nunez appointed as Head, Group Operations 01.07.2022 / 08:00 Lonza appoints Maria Soler Nunez as Head, Group Operations Maria joins Lonza from Novartis where she has led the quality organization since 2020 Maria will commence her tenure with Lonza Group on 1 August 2022, succeeding Stefan Stoffel, who is retiring from Lonza Basel, Switzerland, 1 July 2022 – Lonza today announced that its Board of Directors has appointed Maria Soler Nunez as the

  • EQS Group

    Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)

    Lonza Group AG / Key word(s): Expansion01-Jul-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Lonza to build a new large-scale, commercial drug product fill and finish facility to support customers across the entire product life cycle Lonza will invest approximately CHF 500 million in the facility, fulfilling its strategic commitment to establish a commerc

  • EQS Group

    Lonza Delivers Strong 2021 performance with 20% CER Sales Growth

    Lonza Group AG / Key word(s): Annual Results26-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Release Pursuant to Art. 53 Listing Rules Lonza delivers CHF 5.4 billion sales and 20% CER1 sales growth CHF 1.7 billion CORE EBITDA resulted in a margin of 30.8% 2021 CAPEX reached 24% of sales, supporting long-term plan to deliver attractive margins through de-risked growth investments Contin